Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Authors
Keywords
-
Journal
NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 24, Issue 7, Pages 578-587
Publisher
Springer Nature
Online
2017-05-29
DOI
10.1038/nsmb.3414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity
- (2016) Marios G Koliopoulos et al. EMBO JOURNAL
- Structural insights into the catalysis and regulation of E3 ubiquitin ligases
- (2016) Lori Buetow et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway
- (2016) Jacint G. Sanchez et al. Cell Reports
- Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
- (2015) M. Andreeff et al. CLINICAL CANCER RESEARCH
- Activation of a Primed RING E3-E2–Ubiquitin Complex by Non-Covalent Ubiquitin
- (2015) Lori Buetow et al. MOLECULAR CELL
- Structural basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains
- (2015) Emma Branigan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains
- (2015) Emma Branigan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- AKT mediates actinomycin D-induced p53 expression
- (2015) Chih-Shou Chen et al. Oncotarget
- Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage
- (2014) Laura A. Tollini et al. CANCER CELL
- Structure of a RING E3 Trapped in Action Reveals Ligation Mechanism for the Ubiquitin-like Protein NEDD8
- (2014) Daniel C. Scott et al. CELL
- Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction
- (2014) Q. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
- (2013) Qingjie Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3
- (2013) Hao Dou et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MDMX contains an autoinhibitory sequence element
- (2013) M. Bista et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small molecules that bind the Mdm2 RING stabilize and activate p53
- (2012) P. Roxburgh et al. CARCINOGENESIS
- Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers
- (2012) Pavlina Dolezelova et al. CELL CYCLE
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- Structure of an E3:E2∼Ub Complex Reveals an Allosteric Mechanism Shared among RING/U-box Ligases
- (2012) Jonathan N. Pruneda et al. MOLECULAR CELL
- Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis
- (2012) Anna Plechanovová et al. NATURE
- BIRC7–E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer
- (2012) Hao Dou et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
- (2011) Q. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanism of ubiquitylation by dimeric RING ligase RNF4
- (2011) Anna Plechanovová et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
- (2011) V. Pant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy
- (2010) Meng Ling Choong et al. CELL CYCLE
- Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase
- (2010) Saravanakumar Iyappan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
- (2008) K Linke et al. CELL DEATH AND DIFFERENTIATION
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now